DIA Conference in India is Rescheduled

Article

Company News Release

DIA has rescheduled its 3rd Annual Conference on Drug Discovery and Clinical Development in India, which was recently postponed due to recent violence in the area.

MUMBAI, INDIA—DECEMBER 18, 2008—

The Drug Information Association (DIA)

has rescheduled its

3rd Annual Conference on Drug Discovery and Clinical Development in India

 (February 25-28, 2009; Mumbai, India).

“I would like to thank everyone for their patience and understanding for the inconvenience caused by the postponement,” says Sultan Ghani, DIA India Director. “I can assure you that DIA remains committed to its presence in India and is working with the host hotel to make sure that this meeting offers you the best educational and networking experience, under the safest and most secure conditions possible.”

Driven by the need to improve R&D productivity and efficiency and the desire to access untapped markets, global pharmaceutical companies have increasingly off shored and outsourced operations to India. A wide array of factors, however, can dictate whether such a move is successful. DIA will convene global experts from industry, academia, and regulatory for a provocative discussion on the challenges and issues facing drug discovery and clinical development in India. Topics will include:

• Development of Medical Devices: Global Regulatory Requirements
• Opportunities for Establishing Globally Centralized Laboratories in India
• India’s Patent Laws and their impact on Biopharmaceutical Industry
• India vs. ICH Regulatory Framework for Safety Reporting
• Bioinformatics and Biometrics
• Clinical Trials
• Combination Products
• Drug Delivery
• Drug Discovery
• Development of Anticancer Drugs and Biologics: PK
• Development of Biologics
• Pharmacology and Toxicology
• Pharmacovigilance
• Quality-by-Design
• Vaccine – The Challenge for Regulatory and Innovators
• Ethics in Clinical Research

About the Drug Information Association (DIA)

DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit

www.diahome.org

or call 215-442-6100.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.